Company intelligence / Profile preview

Appiell

Plano, Texas, United Statesappiell.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Appiell has validated its AI-driven digital health platform through a multi-site pilot study across the US, demonstrating objectivity and accuracy for skin condition assessments in both clinical practice and clinical trials. The company’s SMARTtrial software is being adopted by CRO partners to streamline decentralized/virtual trials with improved compliance, data collection, and real-time reporting[4][5][9].

Therapeutic areas: Dermatology
Modalities: DeviceSoftware
Industry: Digital Health Medical Devices

Partnerships

Symbio Research (global full-service CRO partnership for marketing/promoting SMARTtrial)

Beyond the preview

Go deeper on Appiell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Appiell.

Explore the full profile